SCHEMBL8043238

SCHEMBL8043238

CCN1CCC(CNCC2CCCCC2)CC1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.49
HSD11B1 P28845 2/20 0.47
EPHX1 P07099 3/20 0.44
EPHX2 P34913 1/20 0.44
ACHE P22303 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH4 P08319 1/20 0.41
ADH7 P40394 1/20 0.41
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
CHRM5 P08912 1/20 0.39
ADRA2C P18825 1/20 0.39
KDM4E B2RXH2 1/20 0.38
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15806858 0.83 EPHX1 (0.46) CXCR4HSD11B1EPHX1EPHX2SMN1; SMN2
SCHEMBL7738185 0.81 HSD11B1 (0.47) HSD11B1EPHX1EPHX2ACHESMN1; SMN2
SCHEMBL8047471 0.79 NCF1 (0.46) CXCR4EPHX1ADH1BADH1CADH1A
SCHEMBL8030921 0.78 CXCR4 (0.48) CXCR4EPHX1ACHEADH1BADH1C
SCHEMBL711161 0.78 HSD11B1 (0.36) CXCR4HSD11B1EPHX1ACHEADH1B
SCHEMBL1678544 0.78 ADH1B (0.59) CXCR4EPHX1ADH1BADH1CADH1A
SCHEMBL1679033 0.78 ADH1B (0.59) CXCR4EPHX1ADH1BADH1CADH1A
SCHEMBL1679102 0.78 ADH1B (0.59) CXCR4EPHX1ADH1BADH1CADH1A
SCHEMBL12605183 0.77 L3MBTL1 (0.47) CXCR4EPHX1EPHX2SMN1; SMN2GNAI3
SCHEMBL23560045 0.76 EPHX1 (0.41) HSD11B1EPHX1EPHX2SMN1; SMN2GNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071707-A1 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed